Myelodysplastic syndromes trials in Czechia

In Czechia 7 Also abroad 369

7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Where
Brno, Novy Hradec Kralove, Ostrava, Prague, Prague 2
Age
18 years and over
People
225 worldwide
Run by
Takeda
See details and how to joinNCT06499285 · EU 2024-516009-22-00
Phase 2Taking people
Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
Where
Brno, Hradec Králové, Ostrava - Poruba, Prague
Age
18 years and over
People
90 worldwide
Run by
Faron Pharmaceuticals Ltd
See details and how to joinNCT07672769 · EU 2026-526706-33-00
Phase 2Taking people
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Where
Prague
Age
18 years and over
People
210 worldwide
Run by
Takeda
See details and how to joinNCT04419649 · EU 2023-507469-24-00
No phaseTaking people
Early Detection and Screening of Hematological Malignancies - SANGUINE
Where
Olomouc
Age
18 years and over
People
3,000 worldwide
Run by
JaxBio Ltd
See details and how to joinNCT05735704
Phase 3Taking people
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Where
Brno, Hradec Králové, Ostrava, Prague 2
Age
18 years and over
People
490 worldwide
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT06641414 · EU 2024-517247-31-00
Phase 2/3Taking people
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Where
Brno, Ostrava, Prague, Prague 2
Age
18 years and over
People
316 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT04256317 · EU 2024-515098-93-00
Phase 1/2Taking people
Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS
Where
Prague
Age
18 years to 65 years
People
16
Run by
Institute of Hematology and Blood Transfusion, Czech Republic
See details and how to joinNCT07532824